TY  - JOUR
A1  - Roick, Julia
A1  - Berner, Reinhard
A1  - Bernig, Toralf
A1  - Erdlenbruch, Bernhard
A1  - Escherich, Gabriele
A1  - Faber, Jörg
A1  - Klein, Christoph
A1  - Bochennek, Konrad
A1  - Kratz, Christian
A1  - Kühr, Joachim
A1  - Längler, Alfred
A1  - Lode, Holger
A1  - Metzler, Markus
A1  - Müller, Hermann
A1  - Reinhardt, Dirk
A1  - Sauerbrey, Axel
A1  - Schepper, Florian
A1  - Scheurlen, Wolfram
A1  - Schneider, Dominik
A1  - Schwabe, Georg Christof
A1  - Richter, Matthias
T1  - Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational study
T2  - BMC pediatrics
N2  - Background: About 2000 children and adolescents under the age of 18 are diagnosed with cancer each year in Germany. Because of current medical treatment methods, a high survival rate can be reached for many types of the disease. Nevertheless, patients face a number of long-term effects related to the treatment. As a result, physical and psychological consequences have increasingly become the focus of research in recent years. Social dimensions of health have received little attention in health services research in oncology so far. Yet, there are no robust results that allow an estimation of whether and to what extent the disease and treatment impair the participation of children and adolescents and which factors mediate this effect. Social participation is of great importance especially because interactions with peers and experiences in different areas of life are essential for the development of children and adolescents.
Methods: Data are collected in a longitudinal, prospective, observational multicenter study. For this purpose, all patients and their parents who are being treated for cancer in one of the participating clinics throughout Germany will be interviewed within the first month after diagnosis (t1), after completion of intensive treatment (t2) and half a year after the end of intensive treatment (t3) using standardized questionnaires. Analysis will be done by descriptive and multivariate methods.
Discussion: The results can be used to identify children and adolescents in high-risk situations at an early stage in order to be able to initiate interventions tailored to the needs. Such tailored interventions will finally reduce the risk of impairments in the participation of children and adolescents and increase quality of life.
Trial registration: ClinicalTrials.gov: NCT04101123.
KW  - Children and adolescents
KW  - Cancer
KW  - Social participation
KW  - Patient reported outcomes
KW  - Brain tumors
KW  - Leukemia
KW  - Sarcomas
Y1  - 2020
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/52881
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-528811
SN  - 1471-2431
N1  - Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
VL  - 20
IS  - 1, Art. 48
SP  - 1
EP  - 8
PB  - BioMed Central
CY  - London
ER  -